GSK plc 13D and 13G filings for F-star Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 4:50 pm Sale | 2021-12-31 | 13G | F-star Therapeutics, Inc. FSTX | GSK plc | 802,627 3.900% | -1,295 (-0.16%) | Filing |
| 2020-11-30 5:05 pm Purchase | 2020-11-20 | 13G | F-star Therapeutics, Inc. FSTX | GSK plc | 803,922 8.900% | 803,922 (New Position) | Filing |